Global Veterinary Intelligence
Reader login
Veterinary33

Free reader access

Every article remains open. Registration is for participation, not access.

Create a profile to comment, join discussions, receive more relevant recommendations, keep your activity connected, and access selected opportunities.

Latest News · Clinical Study · 2 min read

WSU researcher works to advance peptide-based male contraceptive toward human trials

11 views

New university findings highlight potential implications for veterinary patients, treatment, and veterinary practice.

November 18, 2026 at 2:00 PM UTCWashington State University College of Veterinary MedicineVeterinary33 Editorial Desk

Comments on this article are also part of the Veterinary33 clinical forum.

WSU researcher works to advance peptide-based male contraceptive toward human trials
Washington State University College of Veterinary Medicine

Washington State University Regents Professor Jon Oatley has received a $274,849 grant from the Washington Research Foundation to help prepare Alphatide – a promising peptide-based male contraceptive he developed that works by targeting and inhibiting proteins essential for sperm development – for human clinical trials.

The GLP-1 peptide craze that has transformed weight-loss treatment could soon expand to the bedroom and under the sheets.

Like GLP-1 medications, Alphatide is based on a peptide, a short chain of amino acids, but it targets an entirely different biological process.

“The World Health Organization estimates roughly 50% of pregnancies are unintended globally, and a majority of those unintended pregnancies end in abortion, and in low-income countries, those are not always medically approved abortions,” said Oatley, who is based in the WSU College of Veterinary Medicine’s School of Molecular Biosciences.

“Right now, men have few options for contraception beyond condoms and vasectomy.

Advancing this technology toward clinical trials brings us a step closer to providing a safe, effective, and reversible option that could have a far-reaching impact.” The two-year grant will support the final preclinical studies needed before regulatory approval can be given to begin testing Alphatide in people.

The work will generate data on how the peptide behaves in the body, including where it distributes, how long it remains active, and how quickly it clears the system.

The peptide-based approach may offer advantages over other experimental contraceptives.

Peptides can provide greater target specificity and are broken down naturally by the body into amino acids after use, potentially reducing the risk of unintended side effects, Oatley said.

“To my knowledge, nobody else is working on peptides for male contraception, even though they’re kind of a rage right now with GLP-1 inhibitors,” he said.

“This grant will allow us to generate the data that we will need for us to apply to the U.S.

The report adds to ongoing university-led research relevant to veterinary medicine, animal health, and clinical decision-making.

university website: Washington State University College of Veterinary Medicine

Discussion thread

Community replies

0 replies

No replies yet

No replies yet. Be the first professional to join this discussion.

Join this discussion

Add your reply

Share a professional insight, ask a focused question, or add relevant clinical experience.

Member participation

Log in to join the discussion

Share an answer, ask a question, reply to another professional, or mark useful contributions as helpful.

Log in to reply

Continue the conversation

Share this article with another veterinary professional.

LinkedInEmail
Articles remain free

Create a profile when you are ready to participate.

Veterinary33 does not require registration to read its articles. A free reader profile connects your discussions, recommendations, professional details, and reader activity.

After registration or login, you will return to this exact article.

Registered readers may also receive selected educational and community opportunities.

Join discussions

Comment on articles and participate in professional conversations.

Relevant recommendations

Use your reading and engagement activity to surface more useful articles.

Connected reader activity

Return to your likes, comments, discussions, and article activity in one place.

Professional profile

Add your profession, specialty, workplace, biography, and profile image.

Registration is optional

Continue reading